NEWS
Dehns is now member of the Oslo Cancer Cluster
Dehns Patent and Trade Mark Attorneys recently joined the Oslo…
The PCI Biotech and Ultimovacs collaboration awarded NOK 500,000 from Innovation Norway
The PCI Biotech and Ultimovacs collaboration awarded NOK 500,000 from Innovation Norway
Fantastic opening of the Oslo Cancer Cluster Innovation Park
Oslo Cancer Cluster Innovation Park´s grand opening on August 24th became a very special day: More than 290 invited guests and a huge media turnout celebrated the initiators Jónas Einarsson and Kaare Norum for turning the radical idea of an oncology innovation park integrating a high school into reality.
